Skip to main content
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. — Investor Relations & Filings

Ticker · PPCB ISIN · US74346N4043 LEI · 549300Q3HY827FNV8Y56 US Professional, scientific and technical activities
Open in API
Filings indexed 412 across all filing types
Latest filing 2019-06-28 Director's Dealing
Country US United States of America
Listing US PPCB

About Propanc Biopharma, Inc.

https://www.propanc.com/

Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.

Recent filings

Filing Released Lang Actions
Director's Dealing 2019
Director's Dealing
2019-06-28 English
Regulatory Filings 2019
Regulatory Filings
2019-06-24 English
Share Issue/Capital Change 2019
Share Issue/Capital Change Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a reverse stock split, including details about the stock split ratio, effective date, changes to the trading symbol, and adjustments to options and warrants. It also references the filing of a Certificate of Amendment and Certificate of Correction related to the reverse stock split. This type of announcement about a change in the company's capital structure (reverse stock split) fits the category of a Share Issue/Capital Change. The document is not a full financial report but a regulatory announcement of a capital change event. Therefore, the appropriate classification is SHA (Share Issue/Capital Change). The document length and detail support a high confidence in this classification.
2019-06-21 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-1. It references Rule 461 under the Securities Act of 1933 and is signed by the CEO. The content is a formal request related to the registration process for securities, not a financial report or earnings release. The document length is short (1331 characters) and it is a correspondence related to regulatory filing procedures. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-06-20 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is related to the registration of securities for public offering, including details about the securities, offering price, placement agent, and risk factors. This type of filing is a capital raising document used to register new securities offerings and is not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update filings.
2019-06-14 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving a convertible promissory note and securities purchase agreement, detailing terms of financing and obligations. It includes no financial statements or comprehensive financial analysis but focuses on a financing transaction and related contractual terms. This fits the category of Capital/Financing Update (CAP), as it reports on company fundraising and capital structure changes. The document length is over 11,000 characters, indicating it is a full report rather than a brief announcement. Therefore, the appropriate classification is CAP with high confidence.
2019-05-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.